tiprankstipranks
Trending News
More News >

Kringle Pharma Reports Financial Decline in First Half of 2025

Story Highlights
Kringle Pharma Reports Financial Decline in First Half of 2025

Don’t Miss TipRanks’ Half-Year Sale

Kringle Pharma, Inc. ( (JP:4884) ) has shared an update.

Kringle Pharma, Inc. reported its financial results for the six months ended March 31, 2025, showing a decline in net sales to 35 million yen and a significant operating loss of 511 million yen. The company’s financial position weakened, with total assets decreasing to 2,290 million yen and a lower equity ratio of 69.2%. Despite these challenges, the company maintains its financial forecast for the fiscal year ending September 30, 2025, without revisions.

More about Kringle Pharma, Inc.

Kringle Pharma, Inc. is a company listed on the Tokyo Stock Exchange, operating in the pharmaceutical industry. The company focuses on developing innovative medical treatments and therapies.

Average Trading Volume: 84,928

Technical Sentiment Signal: Buy

Current Market Cap: Yen5.78B

See more data about 4884 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1